Citra Nusantara Gemilang Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp154 (market cap 262.18B, 10.35M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.7× Citra Nusantara Gemilang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 10.35M). Which is the better fit depends on your goals.
| CGAS | RSCH | |
|---|---|---|
Market Cap | 262.18B | 715.5B |
Volume | 10.35M | 30.64M |
Lot | 103.48K | 306.41K |
Turnover | 1.6B | 7.98B |
Average Price | 154.22 | 260.34 |
Value | 1.6B | 7.98B |
Indicative Equilibrium Price | 154 | 256 |
Indicative Equilibrium Volume | 2.6K | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →